Pharma Mar SA operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharma Mar SA with three other
miscellaneous service companies in Europe:
sales of 151.61 million Euro [US$185.57 million]
of which 80%
(1.98 billion Swedish Kronor [US$246.65 million]
of which 63%
was LabTech), and
Bachem Holding AG
based in Switzerland
(236.48 million Swiss Francs [US$246.33 million]
of which 89%
was Active Pharmaceutical Ingredients).
During the year ended December of 2016, sales at
Pharma Mar SA were 180.95 million Euro (US$221.48 million).
decrease of 6.6%
versus 2015, when the company's sales were 193.82 million Euro.
Contributing to the drop in overall sales was the 11.3% decline
in Biotech Sector, from 125.45 million Euro to 111.29 million Euro.
However, these declines were partially offset by the increase in sales of
Consumer Chemical Sector (up 3.4% to 69.66 million Euro)